Introduction
The genus Orbivirus is one of 15 recognised genera within the family Reoviridae. Orbiviruses have genomes composed of ten linear molecules of double-stranded RNA. The genus currently contains 22 recognised species. Over the past two decades, several novel orbiviruses have been isolated from arthropod vectors and fully sequenced, which brings the total number of identified novel Orbivirus species to 33 (Tables I and II) (1, 2) . Orbiviruses are transmitted between their vertebrate hosts by a variety of haematophagous arthropods, although some orbiviruses have no known vectors. Bluetongue virus (BTV), African horse sickness virus (AHSV) and Epizootic haemorrhagic disease virus (EHDV) are the three most economically important orbiviruses and these are all transmitted by adult females of certain Culicoides species (3) .
From an evolutionary perspective, the cell attachment and serotype-determining outer-capsid protein of orbiviruses (OC1) falls into one of three size classes, which correlate with the relevant vectors (4) . The OC1 of Culicoides-borne orbiviruses is designated VP2; that of mosquito-borne orbiviruses is designated VP3; while that of the tick-borne orbiviruses is designated VP4. The VP4 of tick-borne orbiviruses is only 50% the length of the VP2 of Culicoidesborne orbiviruses, while the VP3 of mosquito-borne orbiviruses is ~10% shorter than the VP2 of Culicoidesborne orbiviruses (4) . Evolutionary studies indicate that orbiviruses have co-evolved with their arthropod vectors.
In the past decade, several novel emerging orbiviruses have been isolated from arthropod vectors and/or vertebrate hosts showing clinical signs of disease. Continuing research is attempting to establish the worldwide geographic distribution of these viruses, including Peruvian horse sickness virus and Yunnan orbivirus. However, known zoonotic orbiviruses have been overlooked and their implication in diseases of wildlife, domesticated animals and/or humans has received little attention. This article will review selected emerging/zoonotic orbiviruses other than the economically important BTV, AHSV and EHDV (Table I) . 
Peruvian horse sickness virus
Peruvian horse sickness virus was initially isolated from horses which had died unexpectedly during the rainy season in the Department of San Martin in Peru. Between January and July 1997, more than 100 horses died from an infection with a mortality rate of ~1.25% and a case-fatality rate of ~78%. The epizootic, which lasted seven months, affected eight provinces of San Martin, reaching its peak during periods of particularly heavy rain between March and April of 1997 (6) .
During the 1997 outbreak, isolates were made from the spleens, blood and/or brains of sick horses. They were initially identified by electropherotyping as PHSV isolates and subsequently confirmed through sequencing. PHSV was isolated from serum samples taken from horses showing signs of neurological disease, five to ten days postonset. Some of the isolates were obtained from the brains of horses that showed neurological signs, although anti-PHSV immunoglobulin M (IgM) was not detected, indicating a chronic infection (6) .
During surveillance studies conducted in 2002 in San Martin, several isolates of PHSV were obtained from blood samples taken from apparently healthy horses (6) . PHSV has also been identified in Australia. In April and May 1999, Elsey virus (ELSV) was isolated from the blood and spleens of horses showing neurological signs on Katherine and Elsey stations in the Northern Territory of Australia. Genome characterisation confirmed that ELSV and the Peruvian isolate of PHSV were almost identical (97-100% amino acid identity), indicating that they both belonged to PHSV serotype 1 (PHSV-1). Serogroup-specific enzyme-linked immunosorbent assay (ELISA) showed no cross-reactions using antisera against known orbiviruses such as AHSV and BTV (6).
Blood collected since 1998 throughout the Northern Territory, from both sick and healthy horses, has shown a seroprevalence of antibodies against ELSV of approximately 11%, by IgG ELISA. Weak positive reactions (indirect IgG ELISA) were detected in 11% of sera collected from kangaroos. Sera collected from fruit bats in the Northern Territory between 1996 and 2003 were also tested for IgG antibodies to ELSV and ~35% of sera were shown to be positive, with titres higher than those observed in horses (titres in bats up to 160). Wild and domesticated animals in the Northern Territory were also surveyed. No detectable ELSV-specific antibodies were found in rat sera, although a low prevalence of antibody was found in cattle and pigs (6) .
Yunnan orbivirus
The first isolate of YUOV was identified in 2005 from Culex mosquitoes collected in 1997 in Yunnan Province in southern China. However, YUOV has not been isolated from wild or domesticated animals (5). After the sequencing of its genome, the virus was identified as a member of a novel virus species. Subsequently, multiple isolates belonging to the same species were identified in wild-caught mosquitoes collected in 1999 from various provinces in China. At the time of isolation, the virus was not associated with a specific mammalian host but was shown to replicate in experimentally infected animals, particularly mice (5).
During the 1997 outbreak in San Martin, Peru, YUOV isolates were obtained from the blood and/or brains of sick donkeys, cows, one sheep, and one dog showing signs of neurological disease. The virus was also isolated from the mosquito Ochlerotatus scapularis (6) . These isolates all had a similar electropherotype to members of the species YUOV (5) and were identified as Rioja virus (RIOV). Sequence analyses showed that RIOV and YUOV were almost identical (97% amino acid identity) in the serotype-determining protein and confirmed that RIOV belongs to Yunnan orbivirus serotype 1 (YUOV-1), originally identified in China. The isolation of YUOV from a dog with neurological signs in Peru (6) parallels findings about carnivores in Africa (7) and, more recently, in Belgium (8) infected with BTV. Similarly, in 1995, AHSV was isolated from dogs and this infection was attributed to the ingestion of meat and organs from virus-infected prey species (7).
Middle Point orbivirus (MPOV) was first isolated in Australia in 1998 (9) from a healthy cow in Middle Point (Northern Territory). Sequencing the genome segment which encodes the protein that correlates with this species in mosquito-borne orbiviruses (VP2) demonstrated that MPOV was a member of the YUOV species (99% amino acid identity). However, the amino acid identity in the protein defining the serotype in the mosquito-borne orbivirus (VP3) was low (78%), indicating that MPOV belonged to a distinct serotype of YUOV, designated YUOV-2. A real-time reversetranscription polymerase chain reaction (RT-PCR) assay was developed for MPOV, which showed that more than 150 virus isolates obtained from cattle between 1994 and 2006 were MPOV isolates (9) . YUOV (isolate MPOV) infections have been shown to persist in cattle for up to five months with periods of quiescence, followed by recrudescence of the viral titre (10).
Both YUOV and PHSV have recently been re-isolated in Peru (H. Attoui and M.R. Mendez-Lopez, unpublished data).
Diagnostic assays for Peruvian horse sickness virus and Yunnan orbivirus
In addition to a real-time RT-PCR assay developed specifically for MPOV (9) , sequence comparisons of prototype strains of PHSV from Peru and YUOV from China, Australia and Peru have made it possible to design RT-PCR primers that can be used to specifically amplify and distinguish between genome segments from YUOV and PHSV isolates (6) . Primer sequences and the sizes of PCR products are shown in Table III . These primers were recently used to identify several novel isolates of PHSV from South America (H. Attoui and M.R. Mendez-Lopez, unpublished data). Serological assays were also developed for YUOV and PHSV, based on recombinant expressed VP7 (the immunedominant orbivirus antigen) in bacteria. These assays successfully detected antibodies to PHSV and YUOV in equid sera collected in Peru (H. Attoui and F. Mohd Jaafar, unpublished data).
Equine encephalosis virus
Equine encephalosis virus (EEV) is associated with mild or subclinical disease in horses in southern Africa (11 
Diagnostic assays for Equine encephalosis virus
A group-specific, competitive ELISA has been developed for EEV, based on a guinea pig polyclonal serum. This ELISA detects antibodies against all seven serotypes of EEV with a sensitivity and specificity of 100% (14) . This test provides the means for a differential diagnosis between EEV and AHSV. A real-time PCR assay targeting genome segment 7 of EEV was also recently developed (15) . The assay uses group-specific EEV primers (EEVVP7_F0028_ 0048: 5′-GATAGCGGCTAGAGCCCTTTC-3′ and EEVVP7_ R0085_0106: 5′-AACTTGAGGAGCCATRGTAGCT-3′) and a TaqMan ® MGB ™ hydrolysis probe (EEVVP7_P0054_ 0072_MGBTM probe: 5′-TAAGAGCATGTGTTACTGC-3′) to allow the detection of a median tissue culture infective dose (TCID 50 ) as small as 10 2.9 TCID 50 /ml of blood (with 95% confidence).
A recombinant VP7-based indirect ELISA has also been developed for EEV (unpublished data).
Palyam virus
Palyam viruses have been isolated from Culicoides biting midges and culicine mosquitoes. Isolates of Palyam virus infect cattle, goats and sheep (with clinical signs in cattle and goats only), and have been repeatedly isolated from aborted bovine fetuses. Chuzan virus (CHUV) is an isolate of Palyam virus which causes epizootics of congenital abnormalities, particularly hydranencephaly cerebellar hypoplasia syndrome, which occurred in Japan in 1985 and 1986 (16, 17) . CHUV was isolated in Japan between 1987 and 1996 on several occasions, without any major outbreaks being recorded. It has also been isolated from Culicoides oxystoma in Japan (17) . Serosurveillance of naive Korean goats between 2005 and 2006 identified specific antibodies against CHUV in 1% of the surveyed sera (18) .
In regard to vaccines and diagnostic assays, a trivalent vaccine has been developed (19) to contain chemically inactivated Akabane, Aino and Chuzan viruses (Nisseiken Bovine Abnormal Parturition trivalent inactivated vaccine, Nisseiken Co. Ltd, Japan). A baculovirus-expressed VP7 of CHUV virus has been used to develop an indirect ELISA specific to CHUV and was able to differentiate antibodies against CHUV from those against BTV and EHDV (20).
Zoonotic orbiviruses
Several orbiviruses have been isolated from humans and wild or domesticated animals. In addition, antibodies indicative of orbivirus infection have also been detected in human and animal sera.
Corriparta virus
The species Corriparta virus (CORV) includes six named viruses: -Corriparta virus MRM1 (CORV-MRM1) -CS0109 -V654 -V370 -Acado virus -Jacareacanga virus.
Isolates of CORV have been detected in Australia, Africa and South America (21). Corriparta MRM1 virus was initially isolated from Culex mosquitoes, and the mosquito Aedeomyia catasticta in Queensland, Australia, in 1960. Strains CS0109, V654 and V370 were subsequently isolated in Australia (3, 22, 23, 24) . Acado virus was isolated from pools of Culex mosquitoes collected in Ethiopia in 1963 and Jacareacanga virus from pools of Culex mosquitoes in Brazil in 1975 (21, 22) . Isolates of CORV have been obtained from wild birds. Neutralising antibodies to CORV have been identified in humans, equids, cattle, marsupials and birds (25, 26, 27) .
In terms of diagnostic assays for CORV, deoxycholatetreated cell lysates of CORV-infected baby hamster kidney-(BHK-) 21 cells have been used to develop an indirect ELISA (28) . More recently, an indirect ELISA based on bacterially expressed recombinant VP7 of CORV has been developed, which showed no cross-reaction with other orbiviruses, including BTV, PHSV and YUOV (H. Attoui and F. Mohd Jaafar, unpublished data).
Changuinola virus
The species Changuinola virus (CGLV) contains 12 'named' serotypes that have been isolated from phlebotomine sandflies (3).
Changuinola virus was isolated from a human with a brief febrile illness in Panama (4, 22) . The virus has also been isolated from phlebotomine sandflies, and antibodies were detected in rodents. Changuinola virus replicates in mosquito cell lines (in the same way as BTV replicates in C6/36 [Aedes albopictus cells]), Culicoides sonorensis KC cells and African green monkey kidney Vero cells. CGLV is pathogenic for newborn mice or hamsters by intracerebral inoculation (22, 29) . Historically, seven strains of CGLV were isolated from wildcaught sloths (Bradypus variegatus and Choloepus hoffmanni) in central Panama (30) . Several strains were associated with prolonged or recrudescent viraemia in sloths (4). Antibodies against CGLV were widespread in both sloth species and especially prevalent in Choloepus, but virtually absent from all other wild vertebrate species tested (30) . Antibodies to CGLV were detected in rodents (29) . (32) . Isolates of TRBV were obtained from sentinel goats in the Tribec region (Slovakia). Antibodies against TRBV have been identified in cattle (4-31%) and goats (2.5-5%) in the Tribec region (22) .
Kemerovo virus
Kemerovo virus is also suspected in the aetiology of some chronic neurological diseases, including polyradiculoneuritis and multiple sclerosis. Antibodies against a Kemerovo-related virus have been detected in Oklahoma and Texas, in patients with Oklahoma tick fever (33) .
A SYBR Green-based real-time PCR assay to diagnose viruses of the Kemerovo group has been developed (orbitickForsybr: 5′-GAGCAGCGGATTACYTCAGCAA-3′ and orbitickRevsybr: 5′-ACGTCTCGRGGSCGCGTCTG-3′) and validated, using cell culture isolates of KEMV, LIPV and TRBV, mixed with uninfected sheep blood (H. Attoui and F. Mohd Jaafar, unpublished data). As few as 12 genome copies can be detected using this assay.
A serological assay based on the bacterially expressed VP7 of KEMV is also available (H. Attoui and F. Mohd Jaafar, unpublished data).
Orungo virus
The species Orungo virus (ORUV) contains four distinct serotypes (ORUV-1 to ORUV-4), which are transmitted by Anopheles, Aedes and Culex mosquitoes (3, 4, 33 
